Open House Rebate Agreements for Hydrocortisone 10mg Tablets/ Film Tablets
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Hydrocortison in der Wirkstärke 10mg in den Darreichungsformen Tabletten und Filmtabletten, ATC H02AB09
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume disclosed; the agreement is a discount contract with no guaranteed revenue. Revenue depend...
Contracts can be terminated with one month's notice. Buyers may also terminate if alternative contracts are concluded...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Feb 2028
- Provision of Hydrocortisone 10mg (ATC H02AB09) in tablet and film tablet forms
- Conclusion of non-exclusive rebate agreements under §130a SGB V with AOK Bayern
Show full summary
This is an open-house model (not a public procurement procedure) for non-exclusive pharmaceutical discount agreements under §130a SGB V. The AOK Bayern invites all interested pharmaceutical companies to conclude identical, non-negotiable rebate contracts for Hydrocortisone 10mg tablets/film tablets (ATC H02AB09). No competitive selection; any eligible company can join. Contracts run from earliest March 1, 2026, to February 29, 2028. Submission is possible every month until Jan 3, 2028. No estimated value or volume is disclosed.
Risks
No estimated value or volume disclosed; the agreement is a discount contract with no guaranteed revenue. Revenue depend...
Contracts can be terminated with one month's notice. Buyers may also terminate if alternative contracts are concluded...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible to participate
Administrative
- Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
- Submission of signed contract and annex listing the specific pharmaceutical products
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Rebate Agreements for Hydrocortisone 10mg Tablets/ Film Tablets
Single lot covering all pharmaceutical products with active ingredient Hydrocortisone 10mg, in tablet and film tablet forms, ATC H02AB09. Non-exclusive rebate agreements offered to all qualified pharmaceutical companies on identical terms.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Hydrocortison in der Wirkstärke 10mg in den Darreichungsformen Tabletten und Filmtabletten, ATC H02AB09
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 13 Jan 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 22791-2026
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated value or volume disclosed; the agreement is a discount contract with no guaranteed revenue. Revenue depend...
Contracts can be terminated with one month's notice. Buyers may also terminate if alternative contracts are concluded...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications